Renowned Scientist Christopher Mason, Ph.D. and Quantum-Si Collaborate for Exclusive GenomeWeb Webinar
27 Febbraio 2024 - 2:30PM
Business Wire
Quantum-Si Incorporated (NASDAQ: QSI):
WHAT: Esteemed scientist Christopher Mason, Ph.D., of
Weill Cornell Medicine, is set to discuss his Two Frontiers Project
during an exclusive webinar hosted by GenomeWeb. Dr. Mason will
also reveal his plans for using Quantum-Si’s benchtop protein
sequencer, Platinum® to expand his multiomic research on
extremophiles and what is needed for human survival in extreme
environments.
WHY: Dr. Mason recently remarked, “To better understand
disease and health, we must not only look at nucleic acids, but
also other molecules and pivotal proteins. In recent years, the
field of proteomics has surged forward. We are now experiencing a
remarkable acceleration with advancements in protein sequencing,
revealing new biology and post-translational modifications.”
WHO: The webinar will feature:
- Christopher Mason, Ph.D., Professor of Genomics, Physiology,
and Biophysics at Weill Cornell Medicine
- Kenneth Skinner, Ph.D., Staff Scientist, Quantum-Si
WHEN: The webinar, titled “Characterizing Far-Flung
Extremophiles with Next-Generation Protein Sequencing™,” will take
place on Wednesday, February 28, at 11:00 a.m. ET.
WHERE: Hosted online by GenomeWeb. Reserve your spot
today:
https://event.on24.com/wcc/r/4461798/062AF09F1284EB44601D82D2A32B9869?partnerref=QSI
About Quantum-Si Incorporated
Quantum-Si, The Protein Sequencing Company™, is focused on
revolutionizing the growing field of proteomics. The Company’s
suite of technologies is powered by a first-of-its-kind
semiconductor chip designed to enable next-generation
single-molecule protein sequencing and digitize proteomic research
in order to advance drug discovery and diagnostics beyond what has
been possible with DNA sequencing. Learn more at quantum-si.com or
follow us on LinkedIn or X.
About Christopher Mason, Ph.D.
Christopher Mason, Ph.D., is a Professor of Genomics,
Physiology, and Biophysics at Weill Cornell Medicine and the
director of the WorldQuant Initiative for Quantitative Prediction.
With over 300 peer-reviewed papers, five patents, and the
foundation of numerous biotechnology companies and non-profits, Dr.
Mason is a leading figure in genomics and predictive algorithms for
medicine. He is also the author of “The Next 500 Years: Engineering
Life to Reach New Worlds.”
View source
version on businesswire.com: https://www.businesswire.com/news/home/20240227306348/en/
Investor Relations Jeff Keyes, Chief Financial Officer
ir@quantum-si.com
Media Relations Katherine Atkinson, SVP of Commercial
Marketing media@quantum-si.com
Grafico Azioni Quantum Si (NASDAQ:QSI)
Storico
Da Set 2024 a Ott 2024
Grafico Azioni Quantum Si (NASDAQ:QSI)
Storico
Da Ott 2023 a Ott 2024